Viking Therapeutics (VKTX) Insider Trading & Ownership

$62.94

-4.16 (-6.20%)

(As of 09/17/2024 ET)

Current Insider Ownership Percentage: 4.70%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $54.64 M

Get VKTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Viking Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VKTX Insider Buying and Selling by Quarter

Ad Brownstone Research

Introducing the Perceptron

On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.

Just click here to register.

Viking Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/21/2024	Brian Lian	CEO	Sell	1,000	$69.90	$69,900.00
8/21/2024	J Matthew Singleton	Director	Sell	5,700	$69.72	$397,404.00
8/19/2024	Brian Lian	CEO	Sell	112,870	$65.80	$7,426,846.00
8/19/2024	J Matthew Singleton	Director	Sell	16,000	$62.22	$995,520.00
8/14/2024	J Matthew Singleton	Director	Sell	20,786	$57.53	$1,195,818.58
7/30/2024	Brian Lian	CEO	Sell	115,859	$57.58	$6,671,161.22
Introducing the Perceptron (Ad) On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016. Just click here to register.
7/30/2024	Marianna Mancini	COO	Sell	18,026	$57.13	$1,029,825.38
5/3/2024	Greg Zante	CFO	Sell	66,756	$74.69	$4,986,005.64
5/1/2024	Marianna Mancini	COO	Sell	281,425	$78.66	$22,136,890.50
2/8/2024	Brian Lian	CEO	Sell	269,079	$26.87	$7,230,152.73
2/8/2024	Sarah Kathryn Rouan	Director	Sell	25,000	$28.05	$701,250.00
1/30/2024	Brian Lian	CEO	Sell	35,000	$23.95	$838,250.00
1/19/2024	Sarah Kathryn Rouan	Director	Sell	30,000	$23.05	$691,500.00
1/4/2024	Greg Zante	CFO	Sell	15,000	$17.90	$268,500.00

(Data available from 1/1/2013 forward)

VKTX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Viking Therapeutics includes Brian Lian, Charles A Rowland Jr, Greg Zante, J Matthew Singleton, Lawson Macartney, Marianna Mancini, and Sarah Kathryn Rouan. Learn more on insiders at VKTX.
: 4.70% of Viking Therapeutics stock is owned by insiders. Learn more on VKTX's insider holdings.
: The following insiders have sold VKTX shares in the last 24 months: Brian Lian ($30,209,585.65), Charles A Rowland Jr ($1,000,000.00), Greg Zante ($9,201,706.64), J Matthew Singleton ($2,588,742.58), Lawson Macartney ($767,720.00), Marianna Mancini ($24,076,587.88), and Sarah Kathryn Rouan ($1,392,750.00).
: Insiders have sold a total of 1,773,070 Viking Therapeutics shares in the last 24 months for a total of $69,237,092.75 sold.

Viking Therapeutics Key Executives

Dr. Brian Lian Ph.D. (Age 58)
President, CEO & Director
Compensation: $987.1k
Mr. Gregory S. Zante (Age 53)
Chief Financial Officer
Compensation: $655k
Ms. Marianne Mancini (Age 59)
Chief Operating Officer
Compensation: $670k
2 recent trades
Mr. Michael Morneau (Age 59)
Vice President of Finance & Administration
Compensation: $375.33k
Dr. Geoffrey E. Barker Ph.D.
Senior Vice President of Pharmaceutical Development